Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake City
Recursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
3 Stocks Poised to Disrupt the Healthcare Market by 2030
Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back
RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Recursion Pharmaceuticals, Inc. (RXRX) Q1 2026 Earnings Call Transcript
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Lags Revenue Estimates
Recursion Reports First Quarter Financial Results and Provides Business Update
Recursion Pharmaceuticals (RXRX) Stock Dips While Market Gains: Key Facts
Recursion Announces Board Transition
Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6
Recursion Pharmaceuticals May Be Losing Ground To Its Peers
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market
Recursion Pharmaceuticals, Inc. (RXRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors
Recursion to Participate in Upcoming Investor Conferences
Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know
1 Beaten-Down AI Stock to Buy and 1 to Avoid
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
2 AI Healthcare Stocks to Buy Right Now
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market
Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years.
Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Recursion Pharmaceuticals (RXRX) Advances While Market Declines: Some Information for Investors
Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Can This AI Stock Bounce Back in 2026?
Recursion Pharmaceuticals, Inc. (RXRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
DNB Asset Management AS Purchases New Position in Recursion Pharmaceuticals, Inc. $RXRX
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates
Recursion Pharmaceuticals, Inc. (RXRX) Q4 2025 Earnings Call Transcript
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
What's in Store for These 5 Medical Companies This Earnings Season?
Recursion To Be Featured in HighRes' Lightning Talk at NVIDIA GTC
Recursion to Participate in Upcoming Investor Conferences
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood Pours $24 Million to This AI Software Stock
Recursion Pharmaceuticals (RXRX) Expected to Announce Quarterly Earnings on Friday
Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider
Recursion Pharmaceuticals Stock Drops: What's Behind It?
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
Applied Digital, Recursion Pharmaceuticals Stocks Drop. Blame Nvidia.
2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off
Baillie Gifford's Strategic Adjustment in Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know
Brokerages Set Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Price Target at $9.40
This $4 Stock Could Be Your Ticket to Millionaire Status